# PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND)

> **NCT01377662** · PHASE2 · COMPLETED · sponsor: **Tong Lee** · enrollment: 30 (actual)

## Conditions studied

- Methamphetamine Dependence
- Cocaine Dependence

## Interventions

- **DRUG:** OND-PR002 and MPh-IR
- **OTHER:** Placebo: Two dextrose capsules for Ond-PR002 and MPh-IR

## Key facts

- **NCT ID:** NCT01377662
- **Lead sponsor:** Tong Lee
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-10-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01377662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01377662, "PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01377662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*